Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also devlops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops gene therapy, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as is in pre-clinical development for gene therapy, next generation DPP1 inhibitor, deimmunized therapeutic protein, and synthetic rescue. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Insmed Incorporated

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Viatris (VTRS) and Insmed (I...

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Viatris (VTRS) and Insmed (INSM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TG Therapeutics (TGTX), Insmed (INSM) and Solventu...

Analysts Conflicted on These Healthcare Names: TG Therapeutics (TGTX), Insmed (INSM) and Solventum Corporation (SOLV)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alpha Cognition Inc (ACOG), Insmed (INSM) and Connec...

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM) and AC Immune SA (ACIU) with bullish s...

Analysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), AC Immune SA (ACIU)

Insmed ( ($INSM) ) has provided an update. On April 7, 2026, Insmed reported topline results from its Phase 2b CEDAR trial of brensocatib in adults...

Insmed Halts Brensocatib Development After Phase 2b Failure

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aquestive Therapeutics (AQST) and Insmed (INSM) with...

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insmed (INSM) and Oxford BioMedica (OXBDF) with bull...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insmed (INSM) and Travere Therapeutics (TVTX). Ins...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insmed (INSM) and Travere Therapeutics (TVTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEH...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS), GE Healthcare Technologies Inc (GEHC) and Insmed (INSM)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insmed (INSM), Addus Homecare (ADUS) and Novo Nord...

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Addus Homecare (ADUS) and Novo Nordisk (NVO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insmed (INSM) and Ansell (ANSLF). Insmed (INSM) William Blair ana...

Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and Ansell (OtherANSLF)

The Invesco QQQ Trust ETF&nbsp;($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), was up 0.78% in Monday’s pre-market trading afte...

Invesco QQQ Trust ETF (QQQ) Daily Update, 3/16/2026

The Invesco QQQ Trust ETF ($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), was up 0.34% in Friday’s pre-market trading. Investor...

Invesco QQQ Trust ETF (QQQ) Daily Update, 3/13/2026

The Invesco QQQ Trust ETF ($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), fell 0.32% in Thursday’s pre-market trading as rising...

Invesco QQQ Trust ETF (QQQ) Daily Update, 3/12/2026

The Invesco QQQ Trust ETF&nbsp;($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), was down 0.02% in Wednesday’s pre-market trading...

Invesco QQQ Trust ETF (QQQ) Daily Update, 3/11/2026

The Invesco QQQ Trust ETF&nbsp;($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), was up 0.03% in Tuesday’s pre-market trading as ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INSM	$160.41	-1.61%	1.97M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INSM	$160.41	-1.6%	1.97M
3
4
5
6

INSM

INSM

No Data Available

Get Insmed Incorporated Data in Excel

Get Insmed Incorporated Data in Excel